Heidi K. Schroeder

786 total citations · 1 hit paper
17 papers, 442 citations indexed

About

Heidi K. Schroeder is a scholar working on Experimental and Cognitive Psychology, Clinical Psychology and Pharmacology. According to data from OpenAlex, Heidi K. Schroeder has authored 17 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Experimental and Cognitive Psychology, 6 papers in Clinical Psychology and 5 papers in Pharmacology. Recurrent topics in Heidi K. Schroeder's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (9 papers), Child and Adolescent Psychosocial and Emotional Development (6 papers) and Attention Deficit Hyperactivity Disorder (4 papers). Heidi K. Schroeder is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (9 papers), Child and Adolescent Psychosocial and Emotional Development (6 papers) and Attention Deficit Hyperactivity Disorder (4 papers). Heidi K. Schroeder collaborates with scholars based in United States and China. Heidi K. Schroeder's co-authors include Jeffrey R. Strawn, Sarah A. Mossman, Sara T. Varney, Melissa P. DelBello, Marissa J. Luft, Drew H. Barzman, Richard Gilman, David E. Fleck, Kim M. Cecil and Jeffrey A. Mills and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Academy of Child & Adolescent Psychiatry and Neuropsychopharmacology.

In The Last Decade

Heidi K. Schroeder

15 papers receiving 437 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Generalized Anxiety Disorder 7-Item Scale in Adolescents with Generalized Anxiety Disorder: Signal Detection and Validation

2017 282 citations Sarah A. Mossman, Marissa J. Luft et al. Annals of Clinical Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heidi K. Schroeder United States	8	254	124	99	58	51	17	442
Sara T. Varney United States	7	251 1.0×	121 1.0×	92 0.9×	58 1.0×	50 1.0×	10	432
Sarah A. Mossman United States	10	275 1.1×	132 1.1×	126 1.3×	61 1.1×	56 1.1×	14	492
Marissa J. Luft United States	5	235 0.9×	71 0.6×	89 0.9×	58 1.0×	22 0.4×	7	388
Lorna Farquharson United Kingdom	11	211 0.8×	122 1.0×	107 1.1×	58 1.0×	50 1.0×	22	501
Sarah Tebeka France	12	201 0.8×	119 1.0×	148 1.5×	120 2.1×	56 1.1×	55	488
Rikke Wesselhöeft Denmark	14	330 1.3×	124 1.0×	136 1.4×	128 2.2×	74 1.5×	35	619
Michael R. Riquino United States	11	322 1.3×	177 1.4×	55 0.6×	99 1.7×	92 1.8×	26	580
Annie St‐Hilaire Canada	11	325 1.3×	67 0.5×	119 1.2×	105 1.8×	44 0.9×	19	554
Hélène Keable United States	7	321 1.3×	50 0.4×	83 0.8×	44 0.8×	48 0.9×	10	464
David Lovas Canada	11	349 1.4×	134 1.1×	216 2.2×	77 1.3×	62 1.2×	17	572

Countries citing papers authored by Heidi K. Schroeder

Since Specialization

Citations

This map shows the geographic impact of Heidi K. Schroeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi K. Schroeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi K. Schroeder more than expected).

Fields of papers citing papers by Heidi K. Schroeder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi K. Schroeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi K. Schroeder. The network helps show where Heidi K. Schroeder may publish in the future.

Co-authorship network of co-authors of Heidi K. Schroeder

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi K. Schroeder. A scholar is included among the top collaborators of Heidi K. Schroeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi K. Schroeder. Heidi K. Schroeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Marusak, Hilary A., Clara G. Zundel, Sarah Rogers, et al.. (2025). Circulating endocannabinoids in children and adolescents: associations with anxiety and the impact of selective serotonin reuptake inhibitors. Neuropsychopharmacology. 50(10). 1606–1614.

Strawn, Jeffrey R., Jeffrey A. Mills, Heidi K. Schroeder, et al.. (2024). Electronically Monitored Antidepressant Adherence in Adolescents with Anxiety Disorders: A Pilot Study. Journal of Child and Adolescent Psychopharmacology. 35(3). 145–154.

Poweleit, Ethan A., et al.. (2024). Letter to the Editor: The Impact of Adherence and CYP2C19 Phenotype on Escitalopram Exposure in Adolescents. Journal of Child and Adolescent Psychopharmacology. 34(1). 67–69. 2 indexed citations

Mills, Jeffrey A., et al.. (2023). Gastrointestinal Symptoms in Pediatric Patients with Anxiety Disorders and Their Relationship to Selective Serotonin Reuptake Inhibitor Treatment or Placebo. Child Psychiatry & Human Development. 56(3). 728–739. 5 indexed citations

Mills, Jeffrey A., et al.. (2022). Executive Functioning in Pediatric Anxiety and Its Relationship to Selective Serotonin Reuptake Inhibitor Treatment Response: A Double-Blind, Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. 32(4). 215–223. 3 indexed citations

Strawn, Jeffrey R., et al.. (2022). Pediatric anxiety and daily fine particulate matter: A longitudinal study. SHILAP Revista de lepidopterología. 2(4). 100077–100077. 2 indexed citations

Lu, Lu, Jeffrey A. Mills, Hailong Li, et al.. (2021). Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial. Journal of the American Academy of Child & Adolescent Psychiatry. 60(10). 1309–1318. 14 indexed citations

Lu, Lu, Hailong Li, Jeffrey A. Mills, et al.. (2021). Acute neurofunctional effects of escitalopram during emotional processing in pediatric anxiety: a double-blind, placebo-controlled trial. Neuropsychopharmacology. 47(5). 1081–1087. 11 indexed citations

Strawn, Jeffrey R., Ethan A. Poweleit, Jeffrey A. Mills, et al.. (2021). Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial. Journal of Personalized Medicine. 11(11). 1188–1188. 10 indexed citations

10.

Croarkin, Paul E., Heidi K. Schroeder, Sara T. Varney, et al.. (2020). Bridging Anxiety and Depression: A Network Approach in Anxious Adolescents. Journal of Affective Disorders. 280(Pt A). 305–314. 27 indexed citations

11.

Lu, Lu, Hailong Li, Jeffrey A. Mills, et al.. (2020). Greater Dynamic and Lower Static Functional Brain Connectivity Prospectively Predict Placebo Response in Pediatric Generalized Anxiety Disorder. Journal of Child and Adolescent Psychopharmacology. 30(10). 606–616. 4 indexed citations

12.

Strawn, Jeffrey R., Jeffrey A. Mills, Heidi K. Schroeder, et al.. (2020). Escitalopram in Adolescents With Generalized Anxiety Disorder. The Journal of Clinical Psychiatry. 81(5). 47 indexed citations

13.

Poweleit, Ethan A., Jeffrey A. Mills, Sara T. Varney, et al.. (2019). 5.7 CYP2C19 METABOLIZER STATUS PREDICTS ESCITALOPRAM PHARMACOKINETICS IN ADOLESCENTS WITH GENERALIZED ANXIETY DISORDER. Journal of the American Academy of Child & Adolescent Psychiatry. 58(10). S247–S247. 1 indexed citations

14.

Strawn, Jeffrey R., Jeffrey A. Mills, Heidi K. Schroeder, et al.. (2019). 5.27 A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ESCITALOPRAM IN ADOLESCENTS WITH GENERALIZED ANXIETY DISORDER. Journal of the American Academy of Child & Adolescent Psychiatry. 58(10). S254–S254. 2 indexed citations

15.

Strawn, Jeffrey R., Lauren L. Vollmer, Jeffrey A. Mills, et al.. (2017). Acid-sensing T cell death associated gene-8 receptor expression in panic disorder. Brain Behavior and Immunity. 67. 36–41. 9 indexed citations

16.

Luft, Marissa J., Heidi K. Schroeder, Sarah A. Mossman, et al.. (2017). Antidepressant Prescribing by Pediatricians: A Mixed-Methods Analysis. Current problems in pediatric and adolescent health care. 47(1). 15–24. 23 indexed citations

17.

Mossman, Sarah A., Marissa J. Luft, Heidi K. Schroeder, et al.. (2017). The Generalized Anxiety Disorder 7-Item Scale in Adolescents with Generalized Anxiety Disorder: Signal Detection and Validation. Annals of Clinical Psychiatry. 29(4). 227–234. 282 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact